Trans American Aquaculture (GRPS) Income from Continuing Operations (2023 - 2025)
Trans American Aquaculture (GRPS) reported Income from Continuing Operations of 171642.0 for Q3 2025, up 70.17% on a YoY basis from 100867.34 in Q3 2024, and up 15.88% quarter-over-quarter from 204038.0 in Q2 2025.
Trans American Aquaculture (GRPS) Income from Continuing Operations (2023 - 2025) Analysis & Trends
Trans American Aquaculture has reported Income from Continuing Operations for 3 years, with the latest figure at 171642.0 in Q3 2025.
- For the quarter ending Q3 2025, Income from Continuing Operations rose 70.17% year-over-year to 171642.0; the trailing twelve-month figure through Sep 2025 stood at 2154625.0 (down 23.83% YoY), and the FY2024 full-year result was 2808894.0, down 48.23% from the prior year.
- Income from Continuing Operations for Q3 2025 stood at 171642.0, up from 204038.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 113707.0 in Q1 2025, with the low at 1665238.0 in Q4 2024.
- Historically, Income from Continuing Operations has averaged 476733.0 across 3 years, with a median of 296068.0 in 2023.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations sank 190.87% — and 2025, when it soared 70.17%.
- Trans American Aquaculture's Income from Continuing Operations stood at 572512.0 in 2023, then sank by 190.87% to 1665238.0 in 2024, then jumped by 89.69% to 171642.0 in 2025.
- The last three Income from Continuing Operations figures came in at 171642.0 (Q3 2025), 204038.0 (Q2 2025), and 113707.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Trans American Aquaculture | - | - | - | -171,642.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -171,642.00 |
| Jun 30, 2025 | -204,038.00 |
| Mar 31, 2025 | -113,707.00 |
| Dec 31, 2024 | -1.67 Mn |
| Sep 30, 2024 | -575,325.00 |
| Jun 30, 2024 | -330,311.00 |
| Mar 31, 2024 | -261,873.00 |
| Dec 31, 2023 | -572,512.00 |
| Sep 30, 2023 | -768,218.00 |
| Jun 30, 2023 | -296,068.00 |
| Mar 31, 2023 | -285,131.00 |